Concert Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Concert Wealth Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-388	Closed	-$17K	–	947
2016 Q3	$17K	Buy	+388	New	+$17.6K	﹤0.01%	916
2014 Q2	–	Sell	-5,008	Closed	-$229K	–	589
2014 Q1	$229K	Sell	5,008 -6,252	-56%	-$295K	0.03%	473
2013 Q4	$499K	Sell	11,260 -2,156	-16%	-$89.8K	0.06%	256
2013 Q3	$515K	Buy	13,416 +6,334	+89%	+$240K	0.07%	247
2013 Q2	$250K	Buy	+7,082	New	+$239K	0.04%	388

Other funds holding XPH

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Concert Wealth Management's XPH Position: Q4 2016 in Review

Concert Wealth Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2016, closing a stake of 388 shares — an estimated $17K sold.

Concert Wealth Management first reported a position in XPH in Q2 2013 and held it in 5 quarters. The position peaked at $515K in Q3 2013. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2016.

Concert Wealth Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
Concert Wealth Management sold 388 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2016, an estimated $17K.
Concert Wealth Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 5 quarters.
Concert Wealth Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $515K in Q3 2013.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2016.

Based on Concert Wealth Management's 13F filing for Q4 2016, filed 10 Feb 2017.